Incyte (INCY) Cash from Investing Activities (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Incyte | 19.28 Bn | 15.27 Bn | 1.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -135.72% |
| Dec 31, 2025 | 21.08% |
| Sep 30, 2025 | -151.25% |
| Jun 30, 2025 | -1,820.33% |
| Mar 31, 2025 | 105.11% |
| Dec 31, 2024 | -156.08% |
| Sep 30, 2024 | -82.10% |
| Jun 30, 2024 | 392.46% |
| Mar 31, 2024 | 52.68% |
| Dec 31, 2023 | -798.83% |
| Sep 30, 2023 | -131.38% |
| Jun 30, 2023 | 73.99% |
| Mar 31, 2023 | -36.57% |
| Dec 31, 2022 | 26.37% |
| Sep 30, 2022 | -127.58% |
| Jun 30, 2022 | 25.48% |
| Mar 31, 2022 | 74.64% |
| Dec 31, 2021 | -101.65% |
| Sep 30, 2021 | 33.35% |
| Jun 30, 2021 | 17.75% |
| Mar 31, 2021 | 41.83% |
| Dec 31, 2020 | -610.79% |
| Sep 30, 2020 | 66.59% |
| Jun 30, 2020 | 60.15% |
| Mar 31, 2020 | -261.53% |
| Dec 31, 2019 | -344.45% |
| Sep 30, 2019 | 127.21% |
| Jun 30, 2019 | -83.80% |
| Mar 31, 2019 | 31.95% |
| Dec 31, 2018 | -101.93% |
| Sep 30, 2018 | -355.79% |
| Jun 30, 2018 | 86.25% |
| Mar 31, 2018 | 80.05% |
| Dec 31, 2017 | -363.71% |
| Sep 30, 2017 | 17.36% |
| Jun 30, 2017 | 73.12% |
| Mar 31, 2017 | -285.48% |
| Dec 31, 2016 | -261.86% |
| Sep 30, 2016 | 95.38% |
| Jun 30, 2016 | -848.62% |
| Mar 31, 2016 | 734.95% |
| Dec 31, 2015 | 70.23% |
| Sep 30, 2015 | 43.00% |
| Jun 30, 2015 | 54.43% |
| Mar 31, 2015 | -1,565.01% |
| Dec 31, 2014 | 94.01% |
| Sep 30, 2014 | -105.62% |
| Jun 30, 2014 | 40.15% |
| Mar 31, 2014 | -139.22% |
| Dec 31, 2013 | -1,887.44% |
| Sep 30, 2013 | 93.61% |
| Jun 30, 2013 | -1,971.50% |
| Mar 31, 2013 | -51.60% |
| Dec 31, 2012 | -100.80% |
| Sep 30, 2012 | 72.64% |
| Jun 30, 2012 | -176.60% |
| Mar 31, 2012 | 71.12% |
| Dec 31, 2011 | -35.43% |
| Sep 30, 2011 | -54.31% |
| Jun 30, 2011 | -2,370.83% |
| Mar 31, 2011 | 101.30% |
| Dec 31, 2010 | -315.32% |
| Sep 30, 2010 | -91.16% |
| Jun 30, 2010 | 48.47% |